← Leaderboards
Rohan Fernandes
George Washington University
$4,639,547
Attributed
$7,424,264
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,424,264 · 7
By mechanism
R37$2,562,258 · 1
R33$1,487,721 · 1
R01$1,204,762 · 1
R42$1,135,290 · 1
R41$599,670 · 2
R21$434,563 · 1
Top collaborators
- Conrad Russell Young Cruz8 shared
- R. Brad Jones5 shared
- Elizabeth E Sweeney3 shared
- Alejandro V Villagra1 shared
Most similar at George Washington University
Same institution · by research overlap
- Conrad Russell Young Cruz$3,056,247
Others in their field
Other Emerging Leaders on “Cells”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$155,695,588
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Evan Z Macosko · Broad Institute, Inc.$33,096,828
- James Dale Berry · Brigham And Women'S Hospital$30,122,905
- Hanjoon Ryu$28,519,898
- Eric C Palm · Florida State University$26,502,247
Research focus
CellsIn VitroEngineeringNanoparticleResponseEfficacy TestingIn VivoPhenotypeImmuneRegimenPublic HealthPrussian BlueTumor AntigensImmunogenic Cell DeathNovel TherapeuticsT-LymphocyteNeoplastic CellInsightAntigensMouse ModelPhotothermal TherapyTumorLasersMolecular
Grant awards (17)
Engineered Glioblastoma-specific T cells using Immunostimulatory Photothermal Nanoparticles$1,135,290
R42 · FY2025 · CA
Photothermal Nanoparticles Immune Engineer Tumor-specific T cells for Adoptive Cell Therapy$369,042
R01 · FY2025 · CA · contact PI
Photothermal Nanoparticles Immune Engineer Tumor-specific T cells for Adoptive Cell Therapy$236,915
R01 · FY2025 · CA · contact PI
Photothermal Nanoparticles Immune Engineer Tumor-specific T cells for Adoptive Cell Therapy$598,805
R01 · FY2024 · CA · contact PI
Engineered Ensemble Nanoimmunotherapies for Cancer$437,707
R37 · FY2024 · CA · contact PI
Engineered Glioblastoma-specific T cells using Immunostimulatory Photothermal Nanoparticles$399,669
R41 · FY2024 · CA
Engineered Ensemble Nanoimmunotherapies for Cancer$451,530
R37 · FY2023 · CA · contact PI
Biomaterials-Enhanced NK Cells for Improved Elimination of the HIV Reservoir$485,681
R33 · FY2022 · AI · contact PI
Engineered Ensemble Nanoimmunotherapies for Cancer$401,491
R37 · FY2022 · CA · contact PI
Biomaterials-Enhanced NK Cells for Improved Elimination of the HIV Reservoir$485,681
R33 · FY2021 · AI · contact PI
Engineered Ensemble Nanoimmunotherapies for Cancer$408,831
R37 · FY2021 · CA · contact PI
Biomaterials-Enhanced NK Cells for Improved Elimination of the HIV Reservoir$516,359
R33 · FY2020 · AI · contact PI
Engineered Ensemble Nanoimmunotherapies for Cancer$422,156
R37 · FY2020 · CA · contact PI
Engineered Ensemble Nanoimmunotherapies for Cancer$440,543
R37 · FY2019 · CA · contact PI
Biomaterials-Enhanced NK Cells for Improved Elimination of the HIV Reservoir$200,479
R21 · FY2019 · AI · contact PI
Biomaterials-Enhanced NK Cells for Improved Elimination of the HIV Reservoir$234,084
R21 · FY2018 · AI · contact PI
An Engineered Nanoimmunotherapy for Melanoma$200,001
R41 · FY2018 · CA